These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 21633949)
1. Outcomes following a limited approach to radiotherapy in rectal cancer. Simunovic M; Jacob S; Coates AJ; Vogt K; Moran BJ; Heald RJ Br J Surg; 2011 Oct; 98(10):1483-8. PubMed ID: 21633949 [TBL] [Abstract][Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision? Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K Am Surg; 1997 Jul; 63(7):579-84; discussion 584-5. PubMed ID: 9202530 [TBL] [Abstract][Full Text] [Related]
4. Long-term results of preoperative radiation therapy alone for stage T3 and T4 rectal cancer. Ahmad NR; Nagle D Br J Surg; 1997 Oct; 84(10):1445-8. PubMed ID: 9361610 [TBL] [Abstract][Full Text] [Related]
5. Tumour location and the effects of preoperative radiotherapy in the treatment of rectal cancer. Holm T; Johansson H; Rutqvist LE; Cedermark B Br J Surg; 2001 Jun; 88(6):839-43. PubMed ID: 11412255 [TBL] [Abstract][Full Text] [Related]
6. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ; Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156 [TBL] [Abstract][Full Text] [Related]
7. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy]. Thomschke D; Kyau-Ummen B; Halbfass HJ Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499 [TBL] [Abstract][Full Text] [Related]
8. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Hansen MH; Kjaeve J; Revhaug A; Eriksen MT; Wibe A; Vonen B; Br J Surg; 2007 Jan; 94(1):113-8. PubMed ID: 17083107 [TBL] [Abstract][Full Text] [Related]
9. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780 [TBL] [Abstract][Full Text] [Related]
10. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Holm T; Johansson H; Cedermark B; Ekelund G; Rutqvist LE Br J Surg; 1997 May; 84(5):657-63. PubMed ID: 9171755 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Wibe A; Rendedal PR; Svensson E; Norstein J; Eide TJ; Myrvold HE; Søreide O Br J Surg; 2002 Mar; 89(3):327-34. PubMed ID: 11872058 [TBL] [Abstract][Full Text] [Related]
12. Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Pettersson D; Holm T; Iversen H; Blomqvist L; Glimelius B; Martling A Br J Surg; 2012 Apr; 99(4):577-83. PubMed ID: 22241246 [TBL] [Abstract][Full Text] [Related]
13. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer. Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464 [TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Tveit KM; Guldvog I; Hagen S; Trondsen E; Harbitz T; Nygaard K; Nilsen JB; Wist E; Hannisdal E Br J Surg; 1997 Aug; 84(8):1130-5. PubMed ID: 9278661 [TBL] [Abstract][Full Text] [Related]
15. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy. Morcos B; Baker B; Al Masri M; Haddad H; Hashem S Eur J Surg Oncol; 2010 Apr; 36(4):345-9. PubMed ID: 20071133 [TBL] [Abstract][Full Text] [Related]
16. Preoperative chemoradiation and coloanal J pouch reconstruction for low rectal cancer. Chaudhry V; Nittala M; Prasad ML Am Surg; 2000 Apr; 66(4):387-93. PubMed ID: 10776877 [TBL] [Abstract][Full Text] [Related]
17. Optimal preoperative assessment and surgery for rectal cancer may greatly limit the need for radiotherapy. Simunovic M; Sexton R; Rempel E; Moran BJ; Heald RJ Br J Surg; 2003 Aug; 90(8):999-1003. PubMed ID: 12905555 [TBL] [Abstract][Full Text] [Related]
18. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Jeyarajah S; Sutton CD; Miller AS; Hemingway D; Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969 [TBL] [Abstract][Full Text] [Related]
19. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650 [TBL] [Abstract][Full Text] [Related]